Oncolytic viruses for cancer immunotherapy

被引：0
|
作者：
Otto Hemminki
João Manuel dos Santos
Akseli Hemminki
机构：
[1] University Health Network and University of Toronto,Division of Urologic Oncology, Department of Surgical Oncology, Princess Margaret Cancer Centre
[2] University of Helsinki,Cancer Gene Therapy Group, Translational Immunology Research Program
[3] Helsinki University Hospital,Department of Urology
[4] TILT Biotherapeutics Ltd,undefined
[5] Helsinki University Hospital Comprehensive Cancer Center,undefined
来源：
Journal of Hematology & Oncology | / 13卷
关键词：
Adenovirus; Oncolytic; Tumor; Cancer; Immunotherapy; Review; Immunology; Immune system; Immunosupression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In this review, we discuss the use of oncolytic viruses in cancer immunotherapy treatments in general, with a particular focus on adenoviruses. These serve as a model to elucidate how versatile viruses are, and how they can be used to complement other cancer therapies to gain optimal patient benefits. Historical reports from over a hundred years suggest treatment efficacy and safety with adenovirus and other oncolytic viruses. This is confirmed in more contemporary patient series and multiple clinical trials. Yet, while the first viruses have already been granted approval from several regulatory authorities, room for improvement remains.
引用
收藏
相关论文
共 50 条
  • [31] Combining Oncolytic Viruses With Cancer Immunotherapy: Establishing a New Generation of Cancer Treatment
    Shi, Tao
    Song, Xueru
    Wang, Yue
    Liu, Fangcen
    Wei, Jia
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [32] Editorial of the Special Issue: Oncolytic Viruses as a Novel Form of Immunotherapy for Cancer
    Guo, Zong Sheng
    Bartlett, David L.
    BIOMEDICINES, 2017, 5 (03)
  • [33] Oncolytic viruses improve cancer immunotherapy by reprogramming solid tumor microenvironment
    Ling Zhang
    Seyed Abbas Pakmehr
    Reza Shahhosseini
    Maryam Hariri
    Azadeh Fakhrioliaei
    Farid Karkon Shayan
    Wenxue Xiang
    Sepideh Karkon Shayan
    Medical Oncology, 41
  • [34] Oncolytic viruses improve cancer immunotherapy by reprogramming solid tumor microenvironment
    Zhang, Ling
    Pakmehr, Seyed Abbas
    Shahhosseini, Reza
    Hariri, Maryam
    Fakhrioliaei, Azadeh
    Shayan, Farid Karkon
    Xiang, Wenxue
    Shayan, Sepideh Karkon
    MEDICAL ONCOLOGY, 2023, 41 (01)
  • [35] Oncolytic viruses as engineering platforms for combination immunotherapy
    Kwame Twumasi-Boateng
    Jessica L. Pettigrew
    Y. Y. Eunice Kwok
    John C. Bell
    Brad H. Nelson
    Nature Reviews Cancer, 2018, 18 : 419 - 432
  • [36] Oncolytic viruses as immunotherapy: progress and remaining challenges
    Aurelian, Laure
    ONCOTARGETS AND THERAPY, 2016, 9 : 2627 - 2637
  • [37] Oncolytic viruses: a new class of immunotherapy drugs
    Howard L. Kaufman
    Frederick J. Kohlhapp
    Andrew Zloza
    Nature Reviews Drug Discovery, 2015, 14 : 642 - 662
  • [38] Oncolytic viruses as engineering platforms for combination immunotherapy
    Twumasi-Boateng, Kwame
    Pettigrew, Jessica L.
    Kwok, Y. Y. Eunice
    Bell, John C.
    Nelson, Brad H.
    NATURE REVIEWS CANCER, 2018, 18 (07) : 419 - 432
  • [39] Oncolytic viruses: a new class of immunotherapy drugs
    Kaufman, Howard L.
    Kohlhapp, Frederick J.
    Zloza, Andrew
    NATURE REVIEWS DRUG DISCOVERY, 2015, 14 (09) : 642 - +
  • [40] Thunder and Lightning: Immunotherapy and Oncolytic Viruses Collide
    Melcher, Alan
    Parato, Kelley
    Rooney, Cliona M.
    Bell, John C.
    MOLECULAR THERAPY, 2011, 19 (06) : 1008 - 1016
12345